tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

VRSKVerisk Analytics

Industrials · Data Processing · Nasdaq

Verisk is a leading data, analytics, and technology provider serving clients in the insurance ecosystem. 10-K, Item 1

Employees
8,000
Headquarters
Jersey City, NJ
CEO
Lee Shavel
Next results
around Feb 17, 2027
Compare with peers → Embed

1 paragraph in Risk Factors of the 10-K filed Feb 18, 2026 with nothing like it in the 10-K filed Feb 26, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.

Compared with the Risk Factors in the latest 10-K of the other 81 Industrials companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.

limit who may call special meetings of stockholders to holders of at least 25% of our common stock;

Read in the 10-K ↗

New in the latest 10-Q

7 paragraphs in the 10-Q filed Nov 5, 2026 with nothing like them in the 10-Q filed Jul 29, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

On July 29, 2026, we completed the acquisition of 100% of the outstanding equity interests of McKenzie Intelligence Services ("MIS"), a geospatial intelligence and event response company specializing in global real-time catastrophe and conflict event analysis, for $ 25.6 million, net of cash acquired. We acquired MIS to expand our Catastrophe and Risk Solutions offerings by integrating its real-time geospatial intelligence with our catastrophe risk modeling, global loss indexes, advanced analytics and risk data. Acquisition-related costs were not material and were expensed as incurred. The results of MIS since the acquisition date and pro forma results of operations were not material to our condensed consolidated financial statements and are, therefore, not presented.

Read in the 10-Q ↗

Pursuant to the related acquisition agreements, we have funded various escrow accounts to satisfy pre-acquisition indemnity and tax claims arising subsequent to the acquisition dates, as well as a portion of the contingent payment. At September 30, 2026 and December 31, 2025, the current portion of the escrows amounted to $ 3.0 million and $ 0.0 million, respectively. At September 30, 2026 and December 31, 2025, the noncurrent portion of the escrows amounted to $ 0.5 million and $ 2.7 million, respectively. The current and noncurrent portions of the escrows have been included in "Other current assets" and "Other noncurrent assets" in our accompanying condensed consolidated balance sheets, respectively.

Read in the 10-Q ↗

As of September 30, 2026, there are no acquisition-related contingent payments for which the sellers of these acquisitions could receive additional payments by achieving the specific predetermined revenue and EBITDA margin earn-out targets for exceptional performance. We believe that the liabilities recorded as of September 30, 2026 and December 31, 2025 reflect the best estimate of acquisition-related contingent payments. The current liability for acquisition-related contingent payments was $ 0.0 million and $ 9.6 million as of September 30, 2026 and December 31, 2025, respectively. There was no associated noncurrent portion of the contingent payments as of September 30, 2026 and December 31, 2025.

Read in the 10-Q ↗

All ASR agreements are accounted for as a treasury stock transaction and forward stock purchase agreement indexed to our common stock. The forward stock purchase agreements are classified as equity instruments under ASC 815-40, Contracts in Entity's Own Equity ("ASC 815-40") and deemed to have a fair value of zero at the respective effective date.

Read in the 10-Q ↗

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Read in the 10-Q ↗

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Read in the 10-Q ↗

Risk Factors

(1) Upon the final settlements of the February ASR Agreements and June ASR Agreements in July 2026, we received 1,271,417 and 119,081 additional shares, respectively, as determined based on the volume-weighted average share price of our common stock, less a discount, of $181.65 and $187.22 per share during the terms of the February ASR Agreements and June ASR Agreements, respectively.

Read in the 10-Q ↗

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Nov 5, 2026 against Item 1A of the 10-K filed Feb 18, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted and underlined). Text on the page, not a score; each links to the filing at sec.gov.

What the 10-Q itself says about its risk factors:
There has been no material change in the information provided under the heading “Risk Factors” in our annual report on our 2025 10-K.

Read in the 10-Q ↗
Added10-Q 2026-11-05 vs 10-K 2026-02-18
We did not have any unregistered sales of equity securities during the period covered by this report.

Read it in the 10-Q at sec.gov ↗

Added10-Q 2026-11-05 vs 10-K 2026-02-18
Under the Repurchase Program, we may repurchase stock in the market or as otherwise determined by us. These authorizations have no expiration dates and may be suspended or terminated at any time. On February 13, 2026, our Board of Directors approved to increase the total share repurchase authorization to $2.5 billion, inclusive of the then-remaining authorization. As of September 30, 2026, we had $700.0 million in remaining authorization available to rep urchase shares. Our share repurchases for the quarter ended September 30, 2026 are set forth below:

Read it in the 10-Q at sec.gov ↗

Added10-Q 2026-11-05 vs 10-K 2026-02-18
(1) Upon the final settlements of the February ASR Agreements and June ASR Agreements in July 2026, we received 1,271,417 and 119,081 additional shares, respectively, as determined based on the volume-weighted average share price of our common stock, less a discount, of $181.65 and $187.22 per share during the terms of the February ASR Agreements and June ASR Agreements, respectively.

Read it in the 10-Q at sec.gov ↗

Added10-Q 2026-11-05 vs 10-K 2026-02-18
(2) In September 2026, we entered into the September ASR Agreement to repurchase shares of our common stock for an aggregate purchase price of $100.0 million with Royal Bank of Canada. Upon the payment of the aggregate purchase price on September 14, 2026, we received an initial delivery of 454,030 shares of our common stock at an initial price of $176.20 per share. Upon the final settlement of the September ASR Agreement on September 29, 2026, we received 128,245 additional shares, as determ...

Read it in the 10-Q at sec.gov ↗

Work on VRSK in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/VRSK/export.csv") into a cell.